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INTRODUCTION
Beta-thalassemia is a hemolytic disease characterized 
by a gene defect in the production of beta globin chain 
from hemoglobin, which causes a relative excess of alfa-
globin chain, ineffective erythropoiesis, and peripheral 
destruction of red blood cells. Extramedullary hematopoiesis 
(EMH) is a process in which the body attempts to maintain 
erythrogenesis by proliferation of hemopoietic tissue 
outside the bone marrow in response to chronic anemia (1, 
2). This is commonly seen in the liver, spleen, kidney, and 
lymph nodes (1, 2). Occurrence has also been reported in 
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the skin, adrenal gland, thymus, ovary, and pelvic region 
(1, 2). An intracranial EMH is an extremely rare occurrence 
that frequently involves the cranial dura, falx, cerebral 
parenchyma, optic nerve sheath, and diploic space of the 
skull (1-3). Magnetic resonance imaging (MRI) remains the 
modality of choice in investigations. To our knowledge, this 
is the largest intracranial EMH foci reported to date with 
diffusion weighted imaging (DWI) features. 
CASE REPORT 
A 13-year-old boy with beta-thalassemia and complaining 
of progressive weakness of the left side of the body which 
manifested as gait disturbance and has been progressing 
over the last year without any increase in intracranial 
pressure symptoms. The boy’s medical history includes 
a splenectomy performed 10 years earlier, and was on 
intermittent blood transfusions every two months to correct 
anemia. At the time of admission, his general condition 
was fair with a body temperature of 36.2°C, pulse rate of 
95 beats/min, respiratory rate of 21/min, blood pressure 
of 110/70 mm Hg, and pale skin and mucous membrane. 
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On central nervous system (CNS) examination, the boy was 
fully conscious, and well-oriented with a bilateral normal 
pupillary size and reaction. Power of the left-sided limbs 
was graded as 3/5 which is classified as slightly hypertonic 
and hyporeflexia. The right limbs were normal and other 
systemic examinations were unremarkable. His blood 
investigations found a high white blood cell count (14.75 
g/L), very low red blood cell count (0.62 T/L), significantly 
low hemoglobin percentage (10 g/L), very low platelet 
(73 g/L), low albumin to globulin ratio (6.8), moderately 
high total bilirubin (42.6 µmol/L), and elevated indirect 
bilirubin (37.80 µmol/L) and serum iron concentration (43.9 
µmol/L).
The boy underwent a non-contrast computed tomography 
(CT) of the head using a Somatom Plus 4 (Siemens 
Healthcare, Forchheim, Germany). The CT showed a high-
attenuating mass with a density of 45 Hounsfield units 
and a clear margin in the right temporo-parietal region 
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Fig. 1. Intracranial EMH in 13-year-old boy with beta-thalassemia.
A. Axial non-contrast CT showing soft tissue mass with density of 45 Hounsfield units in right temporo-parietal region with smooth margin 
compressing adjacent brain parenchyma. Mass is in close contact with diploic space of skull and displays periosteal reaction. B. T1-weighted MR 
image showing homogeneously slightly high signal intensity mass compared to gray matter with clear margin in right temporo-parietal region, 
causing buckling of white matter, ipsilateral ventricle compression, and midline shift. Uniform thickening of diploic space and skull bone is also 
seen. C-E. Mass showing homogeneously low signal intensity on T2-weighted image (C), fluid attenuation inversion recovery (D) and diffusion 
weighted imaging (E). F. Contrast enhanced coronal T1-weighted image showing significant dural enhancement and moderate enhancement of 
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compressing the lateral ventricle and brain parenchyma 
causing midline shift. The lesion was in close contact with 
the diploic space of the skull bones, which were thickened 
and associated with abnormal bony proliferation (Fig. 1A). 
MRI was performed using a 3.0-T Signa Excite scanner (GE 
Medical Systems, Milwaukee, WI, USA). The MRI revealed 
an extradural mass in the right temporo-parietal region 
measuring 6.6 x 4.8 cm with a clear boundary and a 5 
mm midline shift. In addition diffuse thickening of the 
skull bones and diploic space was observed. T1-weighted 
images showed a mass with a slightly high signal intensity 
compared to gray matter, while low signal intensity was 
seen on T2-weighted images with no perilesional edema. 
Fluid attenuation inversion recovery images showed low 
signal intensity of the mass with adjacent dural high 
signal intensity. Single shot echo planner DWI obtained 
at a b-value of 1000 sec/mm
2, showed homogeneously 
low signal intensity which was consistent on an apparent 
diffusion coefficient (ADC) map. Moderate enhancement of 
the mass and marked enhancement of the dura was seen on 
T1-weighted contrast enhanced images (Fig. 1B-F). 
A surgical exploration and excision of the mass was 
performed, and the resected specimen on Hematoxylin 
and Eosin stain showed multiple foci of mature and 
immature hematopoietic cells of the erythroid, myeloid and 
multinucleated megakaryocytic lineages arranged in row 
patterns (Fig. 1G). About 15-22 megakaryocytes were seen 
in each high power field. Immunohistochemistry showed 
scattered positive reaction to CD20, CD38, CD3, CD79a, 
CD15, CD68 and strong reaction to CD61.
DISCUSSION 
EMH is a process in which the body attempts to maintain 
erythrogenesis by proliferation of pluripotent stem cells 
outside the bone marrow due to less production of blood 
cells in order to meet the body’s demand to compensate for 
anemia. It is observed in hemoglobinopathies (thalassemia, 
sickle cell anemia, leukemia and hereditary spherocytosis), 
myeloproliferative disorders (myeloid metaplasia, 
polycythemia rubravera, myelofibrosis, agnogenic myeloid 
metaplasia), and in neoplasms involving bone marrow and 
metastasis (2). There are two forms of EMH; namely the 
para-osseous in which the normal medullary tissue of the 
bone ruptures to present as a para-osseous mass, which 
occurs more frequently in hemoglobinopathies. In addition, 
extra-osseous masses in which EMH occurs within the soft 
tissue arising from pluripotent stem cells where marrow 
activity is ineffective, usually accompany myeloproliferative 
disorders (2).
Intracranial EMH occurs rarely, and CNS involvement is 
thought to be the proliferation of pluripotent stem cells, 
which occurs in the tissue of mesenchymal origin (4). 
In humans, erythroblasts have been found around the 
meningeal nerve, thus intracranial EMH in children may be 
a representation of persistency of the fetal EMH. CNS cells 
are capable of producing hemopoietic growth factor that 
may also promote the development of EMH (5). Although 
patients are clinically silent, signs and symptoms related 
to raising an intracranial pressure-like headache, visual 
disturbance, papilledema, motor and sensory impairment, 
and even coma may develop. Diagnosis of EMH is based 
on clinical features, laboratory findings, and imaging 
modalities. The classic peripheral blood smear reveals 
a leukoerythroblastic picture with immature white and 
red blood cells, along with circulating megakaryocytes. 
The bone marrow is often fibrotic and the CT appearance 
was first described by Lund and Aldridge as multiple 
extradural masses with an attenuation value equal to or 
higher than gray matter with marked enhancement after 
contrast injection (2). MRI remains the modality of choice 
for showing intermediate to low signal intensity on T1-
weighted images and characteristic low signal on T2-
weighted images (4). This hypointensity is contributed to 
by a magnetic susceptibility effect caused by hemosiderin, 
which is also responsible for low signal intensity in DWI 
Fig. 1. Intracranial EMH in 13-year-old boy with beta-
thalassemia.
G. Pathological examination of postoperative specimen on Hematoxylin 
and Eosin staining showing round to oval cells with erythroblasts, 
megakaryocytes and promyelocytes (magnification, x 400).
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and a drop in ADC (6). Enhancement can be variable on 
MRI, which may be due to the breakdown of the blood-brain 
barrier as reported by Koch et al. (4). Thickening along the 
tentorial and falx with moderate enhancement after contrast 
injection may be seen. The mass may contain adipose tissue 
but calcification is only a rare finding. 
Treatment options for EMH are regular transfusion 
therapy and low dose radiation therapy (1000-3000 cGy). 
Hydroxyurea and myelosuppressive agents have successfully 
been employed for its medical management. Surgical 
treatment is least recommended due to excessive bleeding 
and a higher rate of recurrence. EMH usually regresses or 
disappears after medical treatment.
The differential diagnosis of intracranial EMH includes 
a meningioma, which mainly affects middle age people, 
along with a characteristic MRI finding, which is iso to 
the hypointensity on T1 and hyperintensity on T2, as well 
as iso to low intensity on DWI, showing strong contrast 
enhancement. Neuroblastomas, which account for less than 
1% of primary CNS tumors and more than 50% manifest 
in the first 5 years of life. MR imaging shows low signal 
on T1, T2 weighted images and high signal on DWI with 
strong contrast enhancement. Some areas may reveal high 
signal on both T1- and T2-weighted images, suggesting 
methemoglobin (7). Chloroma is a solid tumor of immature 
granulocytes and usually occurs in patients with acute 
myeloid leukemia, which is usually seen in children with a 
mean age of about 7 to 8 years, typically in the periorbital 
region. MRI demonstrates hypointensity or isointensity on 
both T1 and T2-weighed images, and hyperintensity on 
DWI with homogeneous enhancement following contrast 
administration (8). Granuloma is isointense to brain 
parenchyma on T1-weighted MR images and isointense to 
hypointense on T2-weighted MR images with moderate 
contrast enhancement. Meningeal metastasis rarely presents 
as an isolated dural mass and commonly seen in the adult 
population. It is generally isointense on T1-weighted 
images, hyperintense on T2 and DWI, showing homogeneous 
enhancement after contrast injection (9). EMH can be 
complicated by hemorrhage causing a subdural hematoma 
(10), and arterial thrombosis or infection. Cases of EMH 
have also been reported with pilocytic astrocytomas, 
lipomas, hemangioblastomas (5) and a malignant 
meningioma (3).
In conclusion, the diagnosis of EMH can be established 
on the basis of the radiographic view, especially when it 
occurs in patients with a prolonged history of anemia, or 
in the region where thalassemia is prevalent. Although 
MRI remains the modality of choice of investigation, 
confirmation by biopsy or surgical intervention is mandatory 
in uncertain cases.
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